Ascletis Pharma Inc. (1672.HK)

HKD 2.55

(-10.21%)

Net Debt Summary of Ascletis Pharma Inc.

Ascletis Pharma Inc.'s latest annual net debt in 2023 was -321.7 Million CNY , up 86.96% from previous year.
Ascletis Pharma Inc.'s latest quarterly net debt in 2024 Q2 was -342.99 Million CNY , up 2.58% from previous quarter.
Ascletis Pharma Inc. reported annual net debt of -2.46 Billion CNY in 2022, up 1.05% from previous year.
Ascletis Pharma Inc. reported annual net debt of -2.49 Billion CNY in 2021, up 8.1% from previous year.
Ascletis Pharma Inc. reported quarterly net debt of -342.99 Million CNY for 2024 Q1, down -6.62% from previous quarter.
Ascletis Pharma Inc. reported quarterly net debt of -468.52 Million CNY for 2023 Q1, up 81.01% from previous quarter.

Annual Net Debt Chart of Ascletis Pharma Inc. (2023 - 2016)

Historical Annual Net Debt of Ascletis Pharma Inc. (2023 - 2016)

Year	Net Debt	Net Debt Growth
2023	-321.7 Million CNY	86.96%
2022	-2.46 Billion CNY	1.05%
2021	-2.49 Billion CNY	8.1%
2020	-2.71 Billion CNY	9.14%
2019	-2.98 Billion CNY	5.92%
2018	-3.17 Billion CNY	-422.46%
2017	-607.36 Million CNY	-44.97%
2016	-418.97 Million CNY	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-342.99 Million CNY	2.58%
2024 Q1	-342.99 Million CNY	-6.62%
2023 Q1	-468.52 Million CNY	81.01%
2023 FY	-321.7 Million CNY	86.96%
2023 Q4	-321.7 Million CNY	1.74%
2023 Q3	-327.41 Million CNY	29.84%
2023 Q2	-466.65 Million CNY	0.4%
2022 Q3	-401.94 Million CNY	83.81%
2022 Q2	-2.48 Billion CNY	0.05%
2022 Q1	-2.48 Billion CNY	0.39%
2022 Q4	-2.46 Billion CNY	-513.66%
2022 FY	-2.46 Billion CNY	1.05%
2021 FY	-2.49 Billion CNY	8.1%
2021 Q3	-2.49 Billion CNY	3.09%
2021 Q4	-2.49 Billion CNY	0.06%
2021 Q1	-2.57 Billion CNY	5.03%
2021 Q2	-2.57 Billion CNY	0.08%
2020 Q2	-2.99 Billion CNY	0.06%
2020 Q3	-2.71 Billion CNY	9.37%
2020 Q4	-2.71 Billion CNY	0.04%
2020 Q1	-2.99 Billion CNY	-0.35%
2020 FY	-2.71 Billion CNY	9.14%
2019 Q1	-3.04 Billion CNY	4.19%
2019 FY	-2.98 Billion CNY	5.92%
2019 Q4	-2.98 Billion CNY	0.07%
2019 Q3	-2.98 Billion CNY	1.67%
2019 Q2	-3.03 Billion CNY	0.07%
2018 Q1	-526.02 Million CNY	13.39%
2018 FY	-3.17 Billion CNY	-422.46%
2018 Q4	-3.17 Billion CNY	0.0%
2018 Q3	-3.17 Billion CNY	-417.59%
2018 Q2	-613.07 Million CNY	-16.55%
2017 FY	-607.36 Million CNY	-44.97%
2017 Q1	424.58 Million CNY	0.0%
2017 Q3	-607.36 Million CNY	0.0%
2017 Q4	-607.36 Million CNY	0.0%
2016 FY	-418.97 Million CNY	0.0%

Peer Net Debt Comparison of Ascletis Pharma Inc.

Name	Net Debt	Net Debt Difference
Uni-Bio Science Group Limited	-76.36 Million HKD	-321.246%
CK Life Sciences Int'l., (Holdings) Inc.	5.26 Billion HKD	106.108%